Industry

WINTER PARK, Fla.–(BUSINESS WIRE)–Humata Health today announced plans to make its AI-powered prior authorization technology available with Microsoft Dragon Copilot. By delivering enhanced capabilities within this ambient-powered AI clinical assistant, Humata Health will enable clinicians to automate and streamline crucial prior authorization tasks, ultimately reducing provider burden and accelerating patient access to appropriate care. Humata … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–During the ongoing government shutdown, ClinicalTrials.gov, the nation’s central registry for medical research and clinical studies, has gone offline, leaving millions of patients with cancer and other serious diseases unable to search for potentially life-saving clinical trials. “This should alarm every American,” said Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical & AI … [Read more…]

Wnt/β-catenin pathway, first identified as a key cancer driver over 30 years ago and implicated in millions of cancer cases annually, is not addressed by any currently approved therapies Oral presentation at ESMO 2025 shows FOG-001 – Parabilis’s lead investigational Helicon™ peptide, targeting the β-catenin:TCF interaction – demonstrated tumor reductions in 100% of desmoid patients … [Read more…]

HARMONi-GI3 is the Fourth Global Phase III Study of Ivonescimab and First Global Study beyond NSCLC Clinical Trial Site Activations Planned to Begin This Quarter in the United States Conference Call to be Held at 8:00am ET on Monday, October 20, 2025 MIAMI–(BUSINESS WIRE)–$SMMT–Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced … [Read more…]

The National Measurement Laboratory, Government Chemist and MHRA – three critical national functions of science and safety – brought together in a purpose-designed laboratory facility for the first time GUILDFORD, England–(BUSINESS WIRE)–LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today officially opened its new state-of-the-art National Laboratories facility in Guildford. This … [Read more…]

One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who urgently need them. With this selection, Dompé receives a voucher shortening the marketing application review from the standard 10–12 months to just 1–2 months. Dompé … [Read more…]

The Deeply Personal Documentary Follows Chris and His Father on a Road Trip Back in Time as They Explore the Scientific Impacts Behind Social Connection and Reminiscence Therapy as Methods To Stimulate Mental Activity, Evoke Memories and Improve Well-being — Hopeful Tools in the Fight Against Memory Loss and Cognitive Decline CHRIS HEMSWORTH: A ROADTRIP … [Read more…]

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a … [Read more…]

New Partnership Brings Mucinex Kickstart’s Fast Relief, In-Game Experiences, and High-Energy Spirit to Kings Fans This NHL Season LOS ANGELES–(BUSINESS WIRE)–Two-time Stanley Cup Champions the LA Kings and Mucinex, the #1 most trusted brand among physicians for cough and cold symptoms*, are teaming up for a game-changing partnership designating Mucinex Kickstart as the “Official Cold … [Read more…]

With backing from Peter Thiel, K5 Global, Jeff Bezos, and Wellington Management, among others, HistoSonics is positioned to expand globally across new clinical applications MINNEAPOLIS–(BUSINESS WIRE)–#Funding–HistoSonics, Inc., the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the closing of an oversubscribed $250 million financing led by its new ownership group … [Read more…]